Back

The administration of a CD31 agonist peptide exerts a beneficial effect in experimental heart failure with both reduced and preserved ejection fraction

20 April 2018 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: All day Poster Session - Basic Science - Cardiac Diseases Heart Failure Open Access Frontiers in CardioVascular Biology 2018 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Varouna Syvannarath

Paris (France)

51 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Miss V. Stankovikj (Manchester, GB)
Abstract
Presentation thumbnail
Mr J. Eding (Utrecht, NL)
Abstract
Presentation thumbnail
Associate Professor A. Kiss (Vienna, AT)
Abstract

Access the full session

Session thumbnail
All day Poster Session - Basic Science - Cardiac Diseases

The Event

Event poster

Frontiers in CardioVascular Biology 2018

20 April 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The ghrelin receptor agonist AC01 improves cardiac function in non-human primates and in mice with heart failure by increasing cardiomyocyte contractility
30 August 2024
thumbnail
Congress Presentation
Endothelial dysfunction and hospitalization risk in heart failure with reduced ejection fraction: insights from microvascular reactivity assessment
13 May 2024
thumbnail
Congress Presentation
Estrogen and the estrogen receptor in ZSF1 rats with heart failure with preserved ejection fraction
25 April 2024
thumbnail
Congress Presentation
Photobiomodulation attenuates diastolic functional deterioration in a mouse model of heart-failure with preserved ejection fraction
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources